Lixte Biotechnology Holdings Inc LIXT
$7.21 $0.46 (6.00%) 1D
Last Updated: Jul 02, 12:00 AM·NASDAQ
Pricing for US stocks is delayed by 24 hours
LIXT Shariah Compliance
Screening Methodology: AAOIFI
As of August 2026, Lixte Biotechnology Holdings Inc is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
Lixte Biotechnology Holdings Inc. Stock Analysis LIXT
United States Health Care Micro Cap Lixte Biotechnology Holdings, Inc. is a clinical-stage biopharmaceutical company, which engages in the business of developing a drug class called protein phosphatase 2A inhibitors. The company is headquartered in Boca Raton, Florida and currently employs 3 full-time employees. The company went IPO on 2007-09-21. The firm is focused on identifying new targets for cancer drug development and developing and commercializing cancer therapies. The Company’s product pipeline is primarily focused on inhibitors of protein phosphatase 2A, which is used to enhance cytotoxic agents, radiation, immune checkpoint blockers and other cancer therapies. The Company’s inhibitors of protein phosphatases have significant therapeutic potential for a broad range of cancers. The company is focused on the clinical development of a specific protein phosphatase inhibitor, LB-100. In addition, lead compounds of the LB-100 series have anti-cancer activity in animal models of glioblastoma multiforme, neuroblastoma, and medulloblastoma, all cancers of neural tissue. Its subsidiary, Liora Technologies Europe Ltd., offers electronically controlled proton therapy systems for treating tumors in various types of cancers.
Lixte Biotechnology Holdings Inc (LIXT) Chart
Financial Metrics & Statements of Lixte Biotechnology Holdings Inc (LIXT)
FAQ's for Lixte Biotechnology Holdings Inc (LIXT)
- As of August 2026, Lixte Biotechnology Holdings Inc LIXT is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Lixte Biotechnology Holdings Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in Lixte Biotechnology Holdings Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Lixte Biotechnology Holdings Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Lixte Biotechnology Holdings Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Lixte Biotechnology Holdings Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Lixte Biotechnology Holdings Inc (LIXT)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
